Fate Therapeutics(FATE) - 2019 Q3 - Earnings Call Transcript

Fate Therapeutics, Inc. (NASDAQ:FATE) Q3 2019 Results Conference Call November 5, 2019 5:00 PM ET Company Participants Scott Wolchko - President and Chief Executive Officer Dan Shoemaker - Chief Scientific Officer Bob Valamehr - Chief Development Officer Wayne Chu - Vice President of Clinical Development Conference Call Participants Alethia Young - Cantor Fitzgerald Kelsey Goodwin - Guggenheim Securities Ben Burnett - Stifel Matt Biegler - Oppenheimer Amanda Murphy - BTIG Biren Amin - Jefferies Jim Birche ...